UK cannabis therapy firm to combine with sleep disorder specialist in £5.3bn deal

Posted on by

A UK-based pharmaceutical firm that specialises in a cannabis-derived treatment for epilepsy has agreed to be bought in a $7.2bn (£5.3bn) takeover.
Source: Sky Business News